PRME vs. CRGX, RGNX, MESO, PROK, RLAY, HLVX, HUMA, KYTX, ITOS, and IMTX
Should you be buying Prime Medicine stock or one of its competitors? The main competitors of Prime Medicine include CARGO Therapeutics (CRGX), REGENXBIO (RGNX), Mesoblast (MESO), ProKidney (PROK), Relay Therapeutics (RLAY), HilleVax (HLVX), Humacyte (HUMA), Kyverna Therapeutics (KYTX), iTeos Therapeutics (ITOS), and Immatics (IMTX). These companies are all part of the "biological products, except diagnostic" industry.
CARGO Therapeutics (NASDAQ:CRGX) and Prime Medicine (NYSE:PRME) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings, valuation and community ranking.
Prime Medicine's return on equity of 0.00% beat CARGO Therapeutics' return on equity.
Prime Medicine received 6 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 70.59% of users gave Prime Medicine an outperform vote.
In the previous week, Prime Medicine had 8 more articles in the media than CARGO Therapeutics. MarketBeat recorded 17 mentions for Prime Medicine and 9 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 0.55 beat Prime Medicine's score of 0.50 indicating that Prime Medicine is being referred to more favorably in the news media.
CARGO Therapeutics currently has a consensus price target of $29.00, indicating a potential upside of 42.02%. Prime Medicine has a consensus price target of $15.60, indicating a potential upside of 120.34%. Given CARGO Therapeutics' higher possible upside, analysts clearly believe Prime Medicine is more favorable than CARGO Therapeutics.
93.2% of CARGO Therapeutics shares are owned by institutional investors. Comparatively, 70.4% of Prime Medicine shares are owned by institutional investors. 1.4% of CARGO Therapeutics shares are owned by company insiders. Comparatively, 24.3% of Prime Medicine shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
CARGO Therapeutics and Prime Medicine tied by winning 6 of the 12 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding PRME and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Prime Medicine Competitors List
Related Companies and Tools
